Type I cardiorenal syndrome in patients with acutely decompensated heart failure: the importance of new renal biomarkers.

Atici, A.; Emet, Samim; Cakmak, R.; YURUYEN, G.; Alibeyoglu, Alpay; AKARSU, M.; ARMAN, Yusuf; Kose, M.; OZGUN, Ersin; OZCAN, M.; ALTUN, O.; Onur, I.; Tukek, Tufan

doi:10.26355/eurrev_201806_15180

Type I cardiorenal syndrome in patients with acutely decompensated heart failure: the importance of new renal biomarkers.

Copy For Citation

Atici A., Emet S., Cakmak R., YURUYEN G., Alibeyoglu A., AKARSU M., ...More

European review for medical and pharmacological sciences, vol.22, no.11, pp.3534-3543, 2018 (SCI-Expanded)

Publication Type: Article / Article
Volume: 22 Issue: 11
Publication Date: 2018
Doi Number: 10.26355/eurrev_201806_15180
Journal Name: European review for medical and pharmacological sciences
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.3534-3543
Istanbul University Affiliated: Yes

Abstract

OBJECTIVE: Type 1 cardiorenal syndrome (CRS) is an acute renal failure in patients with acute decompensated heart failure with an incidence of 24% to 45%. The aim of our study was to investigate the significance of new renal biomarkers to predict type 1 CRS.